Skip to main content
. 2022 Jul 20;7(3):285–292. doi: 10.1182/bloodadvances.2022007530

Table 5.

AEs and SAEs

AE and SAE No. of patients, all grades No. of patients, grade ≥3
AEs
 Infection 1 1
 Gastrointestinal disorders
 Esophagitis 1 1
 Mucositis 11 4
 Elevated transaminases 1
 Musculoskeletal disorders 1
 Nutritional disorders 2
SAEs
 Renal failure 1
 Infections requiring hospitalization 2
 Death 10

Adverse events (AEs) and serious AEs (SAEs) directly related to IM-TMI fludarabine-melphalan conditioning are shown.